{"disease":{"id":"low-grade-upper-tract-urothelial-carcinoma","name":"low grade upper tract urothelial carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06668493","title":"Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Ferring Pharmaceuticals","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}